NOAH-AFNET 6: Edoxaban for Atrial High-Rate Episodes: No Help, Some Harm

The randomized trial results indicate that these device-detected events should not be treated broadly with anticoagulation.

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,Hamburg ,Germany ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Eppendorf ,Nordrhein Westfalen ,Daiichi Sankyo ,Edoxaban Savaysa ,Paulus Kirchhof ,Elena Arbelo ,Md University Heart ,European Society Of Cardiology Congress ,University Medical Center Hamburg ,Euroqol Group ,Vascular Center Hamburg ,University Heart ,European Society ,Cardiology Congress ,New England Journal ,Universitat De Barcelona ,